1.
Diagn Microbiol Infect Dis
; 15(4 Suppl): 119S-122S, 1992.
Artigo
em Inglês
| MEDLINE
| ID: mdl-1535578
RESUMO
Roxithromycin 300 mg once daily was compared with clarithromycin 250 mg b.i.d. in an open randomized trial in 200 patients with upper respiratory tract infection: sinusitis, pharyngotonsillitis, and otitis media. Average treatment duration was 9 days. Roxithromycin was more effective (p less than 0.01) particularly in otitis media and pharyngotonsillitis, and better tolerated (only 4% side effects, p less than 0.05).